A detailed history of Greenhouse Funds Lllp transactions in Neogenomics Inc stock. As of the latest transaction made, Greenhouse Funds Lllp holds 4,464,406 shares of NEO stock, worth $68.6 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares
4,464,406
Previous 4,784,941 6.7%
Holding current value
$68.6 Million
Previous $66.4 Million 0.78%
% of portfolio
2.54%
Previous 3.33%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.4 - $17.73 $4.3 Million - $5.68 Million
-320,535 Reduced 6.7%
4,464,406 $65.8 Million
Q2 2024

Aug 14, 2024

BUY
$13.01 - $15.77 $5.06 Million - $6.13 Million
388,587 Added 8.84%
4,784,941 $66.4 Million
Q1 2024

May 15, 2024

BUY
$14.06 - $16.79 $890,321 - $1.06 Million
63,323 Added 1.46%
4,396,354 $69.1 Million
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $4.11 Million - $7.3 Million
352,028 Added 8.84%
4,333,031 $70.1 Million
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $8.34 Million - $12.2 Million
686,186 Added 20.83%
3,981,003 $49 Million
Q2 2023

Aug 14, 2023

BUY
$14.1 - $19.83 $5.14 Million - $7.23 Million
364,803 Added 12.45%
3,294,817 $52.9 Million
Q1 2023

May 15, 2023

BUY
$9.09 - $19.45 $1.23 Million - $2.62 Million
134,783 Added 4.82%
2,930,014 $51 Million
Q4 2022

Feb 14, 2023

BUY
$6.45 - $12.07 $5.07 Million - $9.48 Million
785,363 Added 39.08%
2,795,231 $25.8 Million
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $4.83 Million - $7.94 Million
614,833 Added 44.07%
2,009,868 $17.3 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $5.79 Million - $11.5 Million
820,079 Added 142.63%
1,395,035 $11.4 Million
Q1 2022

May 16, 2022

BUY
$12.15 - $35.28 $6.99 Million - $20.3 Million
574,956 New
574,956 $6.99 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.93B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Greenhouse Funds Lllp Portfolio

Follow Greenhouse Funds Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenhouse Funds Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Greenhouse Funds Lllp with notifications on news.